[1]史 晗,赵晶媛,杨勇锋,等.阿立哌唑联合利培酮治疗对男性精神分裂症患者血清催乳素及糖脂代谢的影响[J].新乡医学院学报,2018,35(6):469-473.[doi:10.7683/xxyxyxb.2018.06.005]
 SHI Han,ZHAO Jing-yuan,YANG Yong-feng,et al.Effect of aripiprazole combined with risperidone on serum prolactin and glucose lipid metabolism in male patients with schizophrenia[J].Journal of Xinxiang Medical University,2018,35(6):469-473.[doi:10.7683/xxyxyxb.2018.06.005]
点击复制

阿立哌唑联合利培酮治疗对男性精神分裂症患者血清催乳素及糖脂代谢的影响
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年6
页码:
469-473
栏目:
临床研究
出版日期:
2018-06-05

文章信息/Info

Title:
Effect of aripiprazole combined with risperidone on serum prolactin and glucose lipid metabolism in male patients with schizophrenia
作者:
史 晗12赵晶媛1杨勇锋12张 燕12李文强12张 岱3吕路线12
(1.新乡医学院第二附属医院精神科,河南 新乡 453002;2.河南省生物精神病学重点实验室,河南 新乡 453002;3.北京大学第六医院精神科,北京 100191)
Author(s):
SHI Han12ZHAO Jing-yuan1YANG Yong-feng12ZHANG Yan12LI Wen-qiang12ZHANG Dai3LYU Lu-xian12
(1.Department of Psychiatry,the Second Affiliated Hospital of Xinxiang Medical University,Xinxiang 453002,Henan Province,China;2.Henan Key Lab of Biological Psychiatry,Xinxiang 453002,Henan Province,China;3.Department of Psychiatry,the Sixth Hospital of Peking University,Beijing 100191,China)
关键词:
精神分裂症男性催乳素阿立哌唑利培酮
Keywords:
schizophreniamaleprolactinaripiprazolerisperidone
分类号:
R749.3
DOI:
10.7683/xxyxyxb.2018.06.005
文献标志码:
A
摘要:
目的 观察阿立哌唑联合利培酮治疗对男性精神分裂症患者血清催乳素(PRL)及糖脂代谢的影响。方法 将2016年10月至2017年5月在新乡医学医院第二附属医院收治的单一长期应用利培酮治疗的男性精神分裂症患者113例分为观察组和对照组。对照组59例患者给予利培酮4~6 mg·d-1,口服;观察组54例患者给予利培酮4~6 mg·d-1联合阿立哌唑10 mg·d-1,口服;疗程均为8周。于治疗前及治疗2、4、8周末测2组患者血清PRL水平;治疗前及治疗4、8周末采用阳性和阴性症状量表(PANSS)对2组患者精神症状进行评估,并测空腹血糖(FPG)、总胆固醇(TC)、三酰甘油(TG)、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)水平及体质量指数(BMI)。结果 治疗前2组患者血清PRL、FPG、TC、TG、HDL、LDL水平、PANSS总分、阳性症状分、阴性症状分、一般病理分及BMI比较差异无统计学意义(P>0.05)。与治疗前比较,治疗2、4、8周末对照组患者血清PRL水平升高(P<0.05),观察组患者血清PRL水平下降(P<0.05)。治疗2、4、8周末2组患者血清PRL水平不同时间点组内两两比较差异有统计学意义(P<0.05)。与对照组比较,观察组患者治疗2、4、8周末血清PRL水平显著低于对照组(P<0.05)。与治疗前比较,治疗4、8周末2组患者PANSS总分、阳性症状分、阴性症状分、一般病理分均显著降低,差异有统计学意义(P<0.05);治疗8周末2组患者PANSS总分、阳性症状分、阴性症状分、一般病理分均显著低于治疗4周末(P<0.05)。治疗4、8周末,观察组患者PANSS总分、阴性症状分、一般病理分均低于对照组(P<0.05);2组患者阳性症状分比较差异无统计学意义(P>0.05)。对照组患者治疗4、8周末FPG、TC、TG、HDL、LDL水平及BMI与治疗前比较差异无统计学意义(P>0.05);观察组患者治疗4周末 FPG、TC、TG、HDL、LDL水平及BMI与治疗前比较差异无统计学意义(P>0.05),治疗8周末FPG、TC、TG、HDL水平与治疗前及治疗4周末比较差异无统计学意义(P>0.05),LDL水平及BMI低于治疗前及治疗4周末(P<0.05)。观察组患者治疗4周末 FPG、TC、TG、HDL、LDL水平及BMI与对照组比较差异无统计学意义(P>0.05);治疗8周末FPG、TC、TG、HDL水平与对照组比较差异无统计学意义(P>0.05),LDL水平及BMI低于对照组(P<0.05)。治疗8周末,对照组患者静坐不能、口干、嗜睡、震颤、恶心、流涎发生率分别为5.08%、10.16%、10.16%、15.25%、6.77%、11.86%,观察组患者静坐不能、口干、嗜睡、震颤、恶心、流涎发生率分别为3.70%、14.81%、9.25%、16.67%、11.11%、9.26%,2组患者静坐不能、口干、嗜睡、震颤、恶心、流涎发生率比较差异无统计学意义(χ2=0.207、0.106、0.159、0.326、0.091、0.162,P>0.05)。结论 阿立哌唑联合利培酮治疗男性精分裂症患者有益于降低利培酮诱导的血清高PRL水平并改善患者脂代谢。
Abstract:
Objective To explore the effect of aripiprazole combined with risperidone on serum prolactin and glucolipid metabolism in male patients with schizophrenia.Methods A total of 113 male patients with schizophrenia who were treated with risperidone in the Second Affiliated Hospital of Xinxiang Medical University from October 2016 to May 2017 were selected.The patients were randomly divided into observation group and control group.Fifty-nine patients in the control group were given risperidone 4-6 mg·d-1 orally,while fifty-four patients in the observation group were given risperidone 4-6 mg·d-1 combined with aripiprazole 10 mg·d-1 orally,the course of treatment was 8 weeks.The serum prolactin(PRL) levels were measured before treatment and at 2,4,8 weeks after treatment.Positive and negative syndrome scale(PANSS)was used to evaluated the psychiatric symptoms in the two groups before treatment and at 4,8 weeks after treatment.The levels of fasting plasma glucose(FPG),total cholesterol(TC),triglyceride(TG),low density lipoprotein(LDL),high density lipoprotein(HDL),body mass index(BMI) were measured in the two groups before treatment and at 4,8 weeks after treatment.Results A total of 113 patients completed the experiment,with 53 cases in the observation group and 59 cases in the control group.There was no significant difference in the level of PRL,FPG,TC,TG,HDL,LDL and the total score,positive symptom score,negative symptom score,general pathologic score of PANSS and BMI between the two groups before treatment(P>0.05).At 2,4,8 weeks after treatment,the level of PRL in the control group was higher than that before treatment(P<0.05),and in the observation group it was lower than that before treatment(P<0.05).Compared between any two time points,there was significant difference in the PRL level at 2,4,8 weeks after treatment in the two groups(P<0.05).Compared with the control group,the level of PRL in the treatment group was significantly lower at 2,4,8 weeks after treatment (P<0.01).The total score,positive symptom score,negative symptom score,general pathologic score of PANSS in the two groups at 4,8 weeks after treatment were lower than those before treatment and at 4 weeks after treatment (P<0.05).The total score,positive symptom score,negative symptom score,general pathologic score of PANSS in the two groups at 8 weeks after treatment were lower than those at 4 weeks after treatment(P<0.05).The total score,negative symptom score,general pathologic score of PANSS in the observation group at 4,8 weeks after treatment were lower than those in the control group(P<0.05),but there was no significant difference in the positive symptom score of PANSS between the two groups at 4,8 weeks after treatment(P>0.05).There was no significant difference in the level of FPG,TC,TG,HDL,LDL and BMI in the control group at 4,8 weeks after treatment compared with that before treatment(P>0.05).There was no significant difference in the level of FPG,TC,TG,HDL,LDL and BMI in the observation group at 4 weeks after treatment compared with that before treatment(P>0.05).There was no significant difference in the level of FPG,TC,TG,HDL in the observation group at 8 weeks after treatment compared with that before treatment and at 4 weeks after treatment(P>0.05).But the level of LDL and BMI in the observation group at 8 weeks after treatment were lower than those before treatment and at 4 weeks after treatment(P<0.05).There was no significant difference in the level of FPG,TC,TG,HDL,LDL and BMI between the observation group and the control group at 4 weeks after treatment(P>0.05).There was no significant difference in the level of FPG,TC,TG,HDL between the observation group and the control group at 8 weeks after treatment (P>0.05).But the level of LDL and BMI in the observation group at 8 weeks after treatment were lower than those in the control group(P<0.05).At 8 weeks after treatment,the incidence rate of akathisia,thirst,somnolence,tremor,nausea and salivation in the control group was 5.08%,10.16%,10.16%,15.25%,6.77%,11.86%,respectively;the incidence rate of akathisia,thirst,somnolence,tremor,nausea and salivation in the observation group was 3.70%,14.81%,9.25%,16.67%,11.11%,9.26%,respectively.There was no significant difference in the incidence rate of akathisia,thirst,somnolence,tremor,nausea and salivation between the two groups(χ2=0.207,0.106,0.159,0.326,0.091,0.162;P>0.05).Conclusion Risperidone combined with aripiprazole in the treatment of male schizophrenia patients is beneficial to reduce the level of serum high PRL induced by risperidone and to improve lipid metabolism.

参考文献/References:

[1] LI H,LUO J,WANG C,et al.Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects:a randomized,double-blind,active parallel-controlled,multicenter clinical trial[J].Schizophr Res,2014,157(1/3):112-119.
[2] PEUSKENS J,PANI L,DETRAUX J.The effects of novel and newly approved antipsychotics on serum prolactin levels:a comprehensive review[J].CNS Drugs,2014,28(5):421-453.
[3] 张理强,林月妹,林家幸.利培酮与阿立哌唑治疗精神分裂症的临床疗效及对血脂、血清催乳素影响的比较观察[J].广东医学院学报,2011,29(6):621-623.
[4] 蔡晓楠,何学莲,吴革菲,等.阿立哌唑治疗儿童Tourette综合征的疗效及安全性Meta分析[J].中华实用儿科临床杂志,2016,31(18):1426-1431.
[5] 刘旭恩,沈姣,张美霞.阿立哌唑联合无抽搐电休克治疗女性难治性精神分裂症疗效观察[J].新乡医学院学报,2017,34(9):847-850.
[6] 吴静娜,王莉艳,刘维丹.2.5、10、15 mg阿立哌唑治疗氨磺必利和利培酮所致高催乳素血症的疗效[J].中国生化药物杂志,2016,36(1):114-115.
[7] 霍丹丹.金刚烷胺、溴隐亭的临床新用[J].中国社区医师,2011,27(2):11.
[8] 魏立和,陈景旭.氨磺必利与利培酮治疗精神分裂症患者疗效及安全性对照研究[J].世界临床药物,2014,35(5):283-286,290.
[9] LEE B J,LEE S J,KIM M K,et al.Effect of aripiprazole on cognitive function and hyperprolactinemia in patients with schizophrenia treated with risperidone[J].Clin Psychopharmacol Neurosci,2013,11(2):60-66.

相似文献/References:

[1]黄远学,王长虹,苏秀芝,等.77例出院后精神分裂症患者心理调查分析[J].新乡医学院学报,1994,11(03):227.
[2]娄百玉,石玉中,韩巍巍,等.未婚女精神分裂症患者父母的心理分析 [J].新乡医学院学报,1994,11(04):375.
[3]郭素芹,吕路线,郭云,等.一次量氯氮平对精神分裂症患者脑电活动的影响[J].新乡医学院学报,1997,14(02):122.
[4]查彩慧 郭国庆.氯丙嗪氯氮平合用治疗精神分裂症临床疗效评价[J].新乡医学院学报,1999,16(04):311.
[5]郭慧荣,张绍荣. 孙富根.利培酮与氯氮平治疗精神分裂症的临床对照研究[J].新乡医学院学报,2001,18(03):174.
[6]李彩霞,张钰,何艳.冬季和夏季出生的精神分裂患者的临床差异[J].新乡医学院学报,2001,18(05):348.
[7]杜云红,郝以辉,王新友.儿童期精神分裂症预后的影响因素分析[J].新乡医学院学报,2001,18(01):058.
[8]扬世昌,祁富生,张疆丽.利培酮治疗精神分裂症2O例[J].新乡医学院学报,2002,19(02):113.
[9]王长虹,李 晏,贾福军,等.工、Ⅱ型精神分裂症患者血清免疫指标的对照分析[J].新乡医学院学报,2002,19(05):360.
[10]孙富根,杜云红,董瑞兰.精神分裂症患者智商和P3o0电位的关系[J].新乡医学院学报,2002,19(05):376.
[11]王素红1,李栓荣1,邱玉华2. 症状自我监控程式训练在稳定期男性精神分裂症患者中的 应用效果 [J].新乡医学院学报,2014,31(08):630.[doi:10.7683/xxyxyxb.2014.08.011]

更新日期/Last Update: 2018-06-05